Cronos Group (CRON) Reports Q2 EPS of $0.15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Cronos Group Reports 2021 Second Quarter Results
August 6, 2021 7:30 AM EDTAmended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids
Announced strategic investment in PharmaCann, a leading U.S. cannabis company
Spinach launched new products in the edible, concentrate, and flower categories in Canada
TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON)Â (TSX: CRON) (Cronos Group or the Company), today announces its 2021 Second Quarter business results.
This quarter, Cronos Group continued to bring high-quality and insight-driven... More



